News & Updates
Showing Oncology articles
Showing
COMS IRIS plaque radiotherapy safe, effective against melanoma
The use of Collaborative Ocular Melanoma Study (COMS) IRIS plaques is an effective treatment approach to iris, iridociliary, and ciliary body melanoma, a recent study has found.
COMS IRIS plaque radiotherapy safe, effective against melanoma
28 Sep 2021
Olanzapine a favourable alternative to dexamethasone for CINV
Olanzapine administered at a dose of 5 mg was noninferior to dexamethasone and is associated with fewer adverse effects than dexamethasone for chemotherapy-induced nausea and vomiting (CINV), according to data presented at ESMO 2021.
Olanzapine a favourable alternative to dexamethasone for CINV
27 Sep 2021
Ribociclib plus letrozole improves OS in hormone receptor–positive, HER2-negative advanced breast cancer
A combined regimen of ribociclib plus letrozole as first-line treatment provides a statistically significant and clinically meaningful overall survival (OS) benefit vs placebo plus letrozole in postmenopausal patients with hormone receptor–positive and HER2-negative advanced breast cancer (BC), results of the phase III MONALEESA-2 study have shown.
